US Patent Issued to University of Washington on Sept. 1 for "Non-viral immuno-targeting" (Washington Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,900, issued on Sept. 1, was assigned to University of Washington (Seattle).

"Non-viral immuno-targeting" was invented by Nicholas P. Whitehead (Seattle) and Stanley C. Froehner (Seattle).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides compositions and methods for delivering a payload to cells or tissues that express GLUT4. In some embodiments, the compositions comprise an antibody, or fragment or derivative thereof, that specifically binds to glucose transporter 4 ("GLUT4") protein, and a therapeutic payload conjugated thereto. In some exemplary embodiments, the compositions are useful for methods of treating a disease or condi...